课题基金 / 基金详情

THE ROLE OF MXIL IN PROSTATE CANCER PROGRESSION

THE ROLE OF MXIL IN PROSTATE CANCER PROGRESSION
MXIL 在前列腺癌进展中的作用
批准号:
6237685
负责人:
DANIEL STEVEN WECHSLER
金额:
$19.65万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-01 至 1998-07-31

项目摘要

项目成果

DANIEL STEVEN WECHSLER的其他基金

相似基金

相关文献

中文摘要
翻译
c-myc原癌基因参与调节正常和 肿瘤细胞生长。 自从发现了马克斯,一种伴侣蛋白, 使c-Myc能够与DNA结合,其他与Max相互作用的基因产物 已经描述了 mxi 1基因的产物是一种蛋白质, 与c-Myc和Max具有显著的同源性,并且其表达 与造血细胞的细胞分化相关。 MXI 1是 被认为与Max,c-Myc和其他 Myc蛋白家族的成员。 在该方案中,c-Myc激活 转录并刺激细胞增殖,而Mxi 1 puristic 负调节这些行动,促进细胞分化。 因此,mxi 1基因的突变或缺失可以防止 在正常水平的存在下, 因此mxi 1是一个潜在的抑癌基因。 我们有 将mxi 1基因定位于染色体长臂的远端部分 10,一个区域被重新排列或大量缺失, 前列腺和脑肿瘤 我们感兴趣的是研究 mxi 1在前列腺细胞生长、分化和瘤形成中的作用 确定以下具体目标: 具体目标#1。MXI 1的完整结构鉴定 基因: a.分离启动子序列以了解mxi 1调控 B.精确识别外显子/内含子边界以帮助突变 分析 C.评估是否存在特异性内含子调控序列 具体目标#2 mxi 1表达对人乳腺癌细胞的影响的表征 细胞生长和分化 a.引入组成型和诱导型mxi 1表达载体 B.确定mxi 1对生长和分化的影响 这些细胞在体外和体内 具体目标#3确定mxi 1在转录调控中的作用 调制 a.确定Mxi 1对c-Myc依赖性转录的影响 在细胞和体外转录测定中 B.研究Mxi 1调节转录的能力 不依赖于c-Myc 具体目标#4评价肿瘤样本的杂合性缺失 (LOH)mxi 1基因座突变 a.筛查前列腺癌的mxi 1洛缺失 B.检查携带LOH的肿瘤中的mxi 1基因突变 C.将含有mxi 1突变的表达载体导入细胞 细胞系以证明MXI 1肿瘤抑制活性的消除。
英文摘要
The c-myc proto-oncogene is involved in the regulation of both normal and neoplastic cell growth. Since the discovery of Max, a partner protein enabling c-Myc to bind to DNA, other gene products which interact with Max have been described. The product of the mxi1 gene is a protein which shares significant homology to c-Myc and Max, and whose expression correlates with cellular differentiation in hematopoietic cells. Mxi1 is thought to be involved in a regulatory network with Max, c-Myc and other members of the Myc protein family. In this scheme, c-Myc activates transcription and stimulates cell proliferation, and Mxi1 putatively negatively regulates these actions, promoting cellular differentiation. Mutations in or loss of the mxi1 gene could therefore prevent differentiation and enhance proliferation in the presence of normal levels of c-Myc, and thus mxi1 is a potential tumor suppressor gene. We have mapped the mxi1 gene to the distal portion of the long arm of chromosome 10, a region which is rearranged or missing in significant numbers of prostate and brain tumors. We are interested in investigating the role of mxi1 in cell growth, differentiation and neoplasia of prostate cells by setting the following specific aims: Specific Aim #1. Identification of the complete structure of the mxi1 gene: a. Isolate promoter sequences to understand mxi1 regulation b. Precisely identify exon/intron boundaries to aid in mutation analysis c. Assess for presence of specific intronic regulatory sequences Specific Aim #2. Characterization of the effects of mxi1 expression on cell growth and differentiation a. Introduce constitutive and inducible mxi1 expression vectors b. Determine the effect of mxi1 on growth and differentiation of these cells both in vitro and in vivo Specific Aim #3. Determination of the role of mxi1 in transcriptional modulation a. Determine the effect of Mxi1 on c-Myc-dependent transcription in both cellular and in vitro transcription assays b. Investigate the ability of Mxi1 to modulate transcription independent of c-Myc Specific Aim #4. Evaluation of tumor samples for Loss of Heterozygosity (LOH) and mutation at the mxi1 locus a. Screen prostate adenocarcinomas for mxi1 LOH b. Examine LOH-bearing tumors for mutations in the mxi1 gene c. Introduce expression vectors containing mxi1 mutations into cells lines to demonstrate abrogation of mxi1 tumor suppressor activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Leukemogenic Transformation by MLL-CALM
  • 批准号:
    7339781
  • 项目类别:
  • 资助金额:
    $19.86万
  • 财政年份:
    2005
  • 负责人:
    DANIEL STEVEN WECHSLER
  • 依托单位:
Mechanisms of Leukemogenic Transformation by MLL-CALM
Mechanisms of Leukemogenic Transformation by MLL-CALM
  • 批准号:
    7627274
  • 项目类别:
  • 资助金额:
    $26.29万
  • 财政年份:
    2005
  • 负责人:
    DANIEL STEVEN WECHSLER
  • 依托单位:
Mechanisms of Leukemogenic Transformation by MLL-CALM
  • 批准号:
    7452401
  • 项目类别:
  • 资助金额:
    $26.29万
  • 财政年份:
    2005
  • 负责人:
    DANIEL STEVEN WECHSLER
  • 依托单位:
海外基金